We've detected a paper from Molecular Cancer that cites a retracted paper post-retraction. Citing paper: https://t.co/u5aWrx92oP Retracted paper: https://t.co/5GPicvTZrF
Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Mar 2023 – Jul 2023Where it's discussed
-
X / Twitter1 posts
-
YouTube1 videos
AI synopsis
What people are saying
Discussions reflect both interest and skepticism, with posts referencing the potential therapeutic targets discussed in the publication, such as immune checkpoint interactions, but also point out issues like citing a retracted paper, which tempers the perceived impact and depth of engagement. The tone varies from cautious optimism to critical concern, influencing the overall moderate scores.
The discussions show mixed reactions; some users acknowledge the importance of understanding tumor-immune interactions, while others express skepticism about certain aspects or point out issues like the citation of retracted papers.
There is moderate interest mainly centered around the significance of targeting cancer stem cells and immune interactions, but some posts show limited enthusiasm or focus on administrative concerns.
Several posts delve into the details, such as the role of immune checkpoints and extracellular vesicles, indicating a moderate level of deep engagement.
The posts highlight that this research could influence future cancer therapies, but some are cautious, indicating a perception of potential rather than immediate groundbreaking change.
Abstract in brief
- Cancer stem cells (CSCs) are a major challenge in cancer treatment because they promote tumor growth, recurrence, and resistance to therapies due to their unique stem-like properties.
- CSCs interact with immune cells and the tumor microenvironment (TME) by using immune checkpoints and releasing various substances like extracellular vesicles, growth factors, and cytokines to evade immune system attacks.
- Understanding the molecular mechanisms of these interactions offers potential for developing new therapies that target the crosstalk between CSCs and the immune system to improve cancer treatment outcomes.
Top posts
Most liked on X and BlueskyAll mentions
Cancer Stem Cell and Immune Cell Interactions as Therapeutic Targets
Cancer stem cells promote tumor growth and resistance by interacting with immune cells through immune checkpoints and secreted factors, providing avenues for developing targeted therapies to enhance cancer treatment.
We've detected a paper from Molecular Cancer that cites a retracted paper post-retraction. Citing paper: https://t.co/u5aWrx92oP Retracted paper: https://t.co/5GPicvTZrF